David Thomson
Consigliere Generale presso MANNKIND CORPORATION
Patrimonio netto: 4 M $ in data 31/05/2024
Posizioni attive di David Thomson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MANNKIND CORPORATION | Consigliere Generale | 01/01/2002 | - |
| Segretario Aziendale | 01/01/2002 | - | |
QrumPharma, Inc.
 QrumPharma, Inc. Pharmaceuticals: MajorHealth Technology QrumPharma, Inc. is engaged in developing drug products. It develops inhalation treatments for severe chronic and recurrent pulmonary infections, including Nontuberculous Mycobacterial (NTM) lung disease. The company was founded by Thomas Hofmann and is headquartered in Doylestown, PA. | Corporate Officer/Principal | - | - |
Storia della carriera di David Thomson
Formazione di David Thomson
| Queen's University | Doctorate Degree |
| University of Toronto | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Canada | 3 |
Posizioni
| Graduate Degree | 2 |
| General Counsel | 1 |
| Corporate Secretary | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MANNKIND CORPORATION | Health Technology |
| Aziende private | 1 |
|---|---|
QrumPharma, Inc.
QrumPharma, Inc. Pharmaceuticals: MajorHealth Technology QrumPharma, Inc. is engaged in developing drug products. It develops inhalation treatments for severe chronic and recurrent pulmonary infections, including Nontuberculous Mycobacterial (NTM) lung disease. The company was founded by Thomas Hofmann and is headquartered in Doylestown, PA. | Health Technology |
- Borsa valori
- Insiders
- David Thomson
- Esperienza
